THE WHAT? Revlon has drafted in MidCap Financial as a replacement for Citi as its collateral and administrative agent on a revolving loan facility. The latter has been in dispute with Revlon’s creditors for some time over funds paid to them by the bank in error.
THE DETAILS According to a report published by Reuters, the amendment to Revlon’s 2016 loan agreement will extend its maturity to May 7, 2024.
THE WHY? Revlon said that Citi remains a partner and it will continue to work with the bank in a ‘number of capacities’, per Reuters. Citi declined to comment when contacted by the news agency.
Clinical aesthetics products refer to a category of products used in the field of medical aesthetics or cosmetic dermatology. These products are typically designed and formulated to be used under the supervision of healthcare professionals, such as dermatologists, plastic surgeons, or trained aestheticians. They are distinct from over-the-counter cosmetics in that they often contain active ingredients or formulations that require expertise in their application or administration.
Examples of clinical aesthetics products include:
-
Dermal Fillers: Injectable substances used to add volume, smooth wrinkles, and enhance facial contours. Examples include hyaluronic acid fillers like Juvederm and Restylane.
-
Botulinum Toxin (Botox): Injectables that temporarily paralyze facial muscles to reduce the appearance of wrinkles caused by repetitive movements, such as frown lines and crow's feet.
-
Chemical Peels: Solutions applied to the skin to exfoliate and improve its texture. They can treat acne, pigmentation issues, and signs of aging.
-
Laser and Light Therapies: Devices that emit focused light or laser energy to treat various skin conditions, including acne, scars, and signs of aging.
-
Prescription Skincare Products: Formulations containing active ingredients like retinoids (vitamin A derivatives), hydroquinone, or prescription-strength antioxidants to address specific skin concerns under medical supervision.
